-
UHRF1, Super-Enhancers, and Osteogenesis in SOP
2026-08-26
A 2026 Journal of Advanced Research study links UHRF1-dependent DNA 5-methylcytosine patterns to super-enhancer redistribution, TGM2-regulated autophagic flux, and impaired mesenchymal stem cell osteogenesis in senile osteoporosis. Its integrated multi-omics and in vivo experiments identify the UHRF1–TGM2 axis as a mechanistically testable connection between epigenetic regulation and age-related bone loss.
-
SmD2 Acetylation Links Splicing to HCC PARP Sensitivity
2026-08-26
A 2024 Nature Communications study identifies SmD2 acetylation as a regulatory connection between core spliceosome activity, BRCA1/FANC cassette-exon selection, DNA-damage repair, and PARP-inhibitor response in hepatocellular carcinoma. The work supports testing SmD2 and the p300–HDAC2 acetylation axis as biomarkers or combination-treatment targets, while showing why findings obtained with olaparib require validation with other PARP inhibitors.
-
Cabazitaxel (XRP6258): Practical Workflow Guide
2026-08-25
Cabazitaxel (XRP6258) is a semi-synthetic taxane derivative for studying microtubule dynamics disruption, including taxane-resistant and P-glycoprotein-expressing cancer models. It is suited to DMSO- or ethanol-based workflows, but it is insoluble in water and prepared solutions should be used promptly rather than stored long term.
-
AZ505: Reframing SMYD2 for Translation
2026-08-25
AZ505 offers a mechanistically defined way to interrogate SMYD2 biology beyond oncology. By combining substrate-competitive inhibition with disease-relevant validation in cisplatin-induced renal fibrosis, researchers can connect epigenetic regulation research to biomarker strategy, assay design, and translational decision-making.
-
Fluorouracil Workflows for Solid-Tumor Research
2026-08-24
Build reproducible Fluorouracil assays around thymidylate synthase blockade, DNA-replication stress, and orthogonal cell-death readouts. This workflow also translates a renal-cell-carcinoma resistance study into practical combination and troubleshooting strategies for colon cancer research, breast cancer research, and other solid-tumor models.
-
SC 79 for Reliable Akt and Viability Assays
2026-08-24
Learn how SC 79 (SKU B5663) can strengthen Akt signaling pathway research while avoiding common interpretation and solubility errors in viability, proliferation, and cytotoxicity assays. This scenario-based guide covers mechanism, controls, preparation, data analysis, and practical vendor-selection criteria.
-
Busulfan Beyond Depletion: A Translational Lens
2026-08-23
Busulfan is both a DNA damage tool and a biological perturbation model. This article connects its chemistry, senescence and germ-cell phenotypes with dual-recombinase lineage tracing to help translational researchers distinguish depletion from regeneration.
-
Targeted mRNA Nanoparticles Protect the Poststroke BBB
2026-08-22
Gao and colleagues developed mannose receptor-targeted lipid nanoparticles that deliver interleukin-10 mRNA to ischemic brain regions and reinforce protective microglial polarization. In mouse stroke models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, while showing activity when administered up to 72 hours after stroke.
-
(-)-Blebbistatin: A Mechanobiology Strategy
2026-08-21
How reversible non-muscle myosin II inhibition can help translational researchers test force-history effects, validate actomyosin–YAP mechanisms, and build more rigorous cell, cardiac, and developmental models.
-
HotStart™ 2X Green qPCR Master Mix Guide
2026-08-20
This scenario-driven guide explains how HotStart™ 2X Green qPCR Master Mix, SKU K1070, can support reproducible gene-expression measurements alongside cell viability, proliferation, and cytotoxicity assays. It translates SYBR Green chemistry, hot-start specificity, workflow controls, and data interpretation into practical laboratory decisions.
-
Co-SAE Multimodal Phototherapy for Head and Neck Cancer
2026-08-20
The reference study develops a near-infrared-triggered cobalt single-atom enzyme anchored on hollow N-doped carbon spheres to integrate photodynamic, photocatalytic, and photothermal therapy. Its central advance is an off-to-on catalytic design in which NIR-generated electrons and heat amplify reactive oxygen species while mild local hyperthermia supports tumor-cell death and tissue preservation.
-
Cisplatin and OSCC Stemness: Assay Logic
2026-08-19
Cisplatin and CDDP are most informative when DNA damage, apoptosis, and cancer stemness are measured together. This guide translates recent OSCC findings into practical assay and xenograft design decisions for resistance-focused cancer research.
-
LEE011 Succinate: CDK Inhibitor Research Guide
2026-08-19
LEE011 succinate is a selective CDK inhibitor used to study CDK4/6-dependent cell cycle regulation and cancer-cell proliferation. Ribociclib succinate has defined solvent and pH-dependent solubility specifications, but clinical oral dosing must not be substituted for an in-vitro concentration.
-
Fluo-4 AM Calcium Assay Kit for Mechanotransduction
2026-08-18
Use live-cell calcium imaging to connect annulus fibrosus scaffold architecture with mechanotransduction, while preserving throughput for biomaterial screening and GPCR programs. This practical guide covers a no-wash workflow, assay controls, optimization parameters, and troubleshooting for reliable Fluo-4 AM measurements.
-
Dhx9 Orchestrates TH17 Autoimmune Transcription
2026-08-18
Su et al. identify the nuclear helicase Dhx9 as a central regulator of TH17 lineage commitment, linking IL-6–STAT3 signaling to chromatin accessibility at the Rorc and Il17 loci. Genetic and pharmacological perturbation reduced TH17 differentiation and autoimmune disease severity in mice, providing a mechanistic framework for studying transcriptional control beyond single-cytokine blockade.